MIRIKIZUMAB-MRKZ

MIRIKIZUMAB-MRKZ was reported 903 times

MIRIKIZUMAB-MRKZ is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTRIC FIBROSIS 4 0.2353
1 URINARY SQUAMOUS EPITHELIAL CELLS INCREASED 1 0.1250
2 CROWNED DENS SYNDROME 1 0.0323
3 INFUSION SITE EXFOLIATION 1 0.0192
4 TESTICULAR INFARCTION 1 0.0167
5 VAGINAL NEOPLASM 1 0.0110
6 BACTERIAL VULVOVAGINITIS 3 0.0104
7 COLORECTAL ADENOMA 3 0.0093
8 ENDOSCOPY ABNORMAL 1 0.0075
9 CARCINOMA IN SITU 1 0.0060
10 CYTOMEGALOVIRUS ENTEROCOLITIS 4 0.0052
11 FAMILIAL MEDITERRANEAN FEVER 1 0.0051
12 GASTROENTERITIS SALMONELLA 4 0.0048
13 STOMA OBSTRUCTION 1 0.0044
14 URINARY OCCULT BLOOD POSITIVE 1 0.0043
15 HERPES ZOSTER CUTANEOUS DISSEMINATED 1 0.0043
16 AMOEBIASIS 1 0.0043
17 TUBERCULOUS PLEURISY 2 0.0042
18 PERIPHERAL VEIN THROMBOSIS 1 0.0042
19 PANCREATIC CARCINOMA RECURRENT 1 0.0041
20 INTESTINAL SEPSIS 1 0.0038
21 LISTERIA SEPSIS 1 0.0038
22 FAECAL CALPROTECTIN INCREASED 11 0.0035
23 COLITIS ULCERATIVE 155 0.0035
24 RELAPSING FEVER 1 0.0035
25 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
26 INCREASED DOSE ADMINISTERED 1 0.0032
27 HEPATIC VEIN THROMBOSIS 1 0.0032
28 CEREBRAL AMYLOID ANGIOPATHY 1 0.0030
29 GIARDIASIS 1 0.0029
30 DIVERTICULITIS INTESTINAL PERFORATED 1 0.0028
31 BODY TINEA 1 0.0018
32 POSTOPERATIVE ILEUS 1 0.0018
33 CELLULITIS ORBITAL 1 0.0017
34 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
35 MEAN PLATELET VOLUME INCREASED 1 0.0017
36 RECTAL ADENOCARCINOMA 1 0.0017
37 INFUSION SITE URTICARIA 1 0.0015
38 HEAD AND NECK CANCER 1 0.0015
39 PNEUMOTHORAX SPONTANEOUS 1 0.0015
40 CUTANEOUS SYMPTOM 1 0.0015
41 ARACHNOIDITIS 1 0.0014
42 MANTLE CELL LYMPHOMA 2 0.0013
43 EXTRADURAL ABSCESS 1 0.0013
44 PRODUCT INEFFECTIVE 1 0.0013
45 ENDOCARDITIS BACTERIAL 1 0.0013
46 HERPES ZOSTER DISSEMINATED 1 0.0012
47 ANAL ULCER 1 0.0012
48 IGA NEPHROPATHY 2 0.0012
49 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
50 ENZYME LEVEL INCREASED 1 0.0012
51 DISSEMINATED TUBERCULOSIS 3 0.0012
52 LUNG HYPERINFLATION 1 0.0012
53 POUCHITIS 1 0.0012
54 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
55 LARGE INTESTINAL ULCER 3 0.0011
56 RECTAL CANCER 3 0.0010
57 CHOLANGITIS SCLEROSING 2 0.0010
58 INFUSION SITE DISCOMFORT 1 0.0010
59 INJECTION SITE HYPERSENSITIVITY 3 0.0010
60 SMALL INTESTINAL STENOSIS 1 0.0009
61 FREQUENT BOWEL MOVEMENTS 25 0.0009
62 CLOSTRIDIUM TEST POSITIVE 2 0.0009
63 CLOSTRIDIAL INFECTION 3 0.0009
64 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
65 PRURITUS ALLERGIC 1 0.0009
66 GROIN ABSCESS 1 0.0008
67 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
68 PYODERMA GANGRENOSUM 3 0.0008
69 PREMATURE RUPTURE OF MEMBRANES 2 0.0008
70 BREECH PRESENTATION 1 0.0008
71 NECROTISING COLITIS 1 0.0008
72 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
73 HYPOVITAMINOSIS 1 0.0008
74 MATERNAL EXPOSURE DURING BREAST FEEDING 3 0.0007
75 INTESTINAL MASS 1 0.0007
76 DEATH NEONATAL 1 0.0007
77 INTESTINAL FISTULA 1 0.0007
78 MYELITIS TRANSVERSE 1 0.0007
79 PNEUMONIA PSEUDOMONAL 1 0.0007
80 MYELITIS 1 0.0006
81 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
82 MEGACOLON 1 0.0006
83 HAEMATOCHEZIA 35 0.0006
84 INFUSION SITE PRURITUS 2 0.0006
85 HEPATITIS E 1 0.0006
86 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
87 INFLAMMATORY BOWEL DISEASE 6 0.0006
88 PAPILLOMA VIRAL INFECTION 1 0.0006
89 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
90 ACUTE SINUSITIS 1 0.0006
91 SERUM FERRITIN DECREASED 1 0.0006
92 DEFAECATION URGENCY 4 0.0006
93 GASTROINTESTINAL OEDEMA 1 0.0006
94 BREAST CYST 1 0.0006
95 OPHTHALMIC HERPES ZOSTER 1 0.0006
96 INTESTINAL ISCHAEMIA 3 0.0005
97 SENSITIVE SKIN 4 0.0005
98 LYMPH NODE PAIN 1 0.0005
99 DIARRHOEA HAEMORRHAGIC 5 0.0005
100 ADENOCARCINOMA OF COLON 1 0.0005
101 SMALL INTESTINAL PERFORATION 1 0.0005
102 STENOSIS 1 0.0005
103 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
104 SACROILIITIS 1 0.0005
105 CONVERSION DISORDER 1 0.0005
106 EARLY SATIETY 1 0.0005
107 HYPERAEMIA 1 0.0005
108 LARGE INTESTINAL STENOSIS 1 0.0005
109 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
110 DIVERTICULAR PERFORATION 1 0.0005
111 VENOUS THROMBOSIS LIMB 1 0.0005
112 VARICELLA ZOSTER VIRUS INFECTION 1 0.0005
113 INJECTION SITE DISCOMFORT 5 0.0005
114 EAR SWELLING 1 0.0005
115 INFUSION SITE BRUISING 1 0.0005
116 MONOPLEGIA 2 0.0005
117 OLIGOMENORRHOEA 1 0.0005
118 HENOCH-SCHONLEIN PURPURA 1 0.0005
119 BACTERIAL TEST POSITIVE 1 0.0004
120 PULMONARY TOXICITY 3 0.0004
121 PRE-ECLAMPSIA 2 0.0004
122 PULSE ABNORMAL 1 0.0004
123 INFLAMMATORY MARKER INCREASED 2 0.0004
124 APPENDICITIS PERFORATED 1 0.0004
125 NOCARDIOSIS 1 0.0004
126 FEMORAL NECK FRACTURE 2 0.0004
127 PHYSICAL DECONDITIONING 1 0.0004
128 HEPATITIS TOXIC 1 0.0004
129 WHITE BLOOD CELL DISORDER 1 0.0004
130 COMPRESSION FRACTURE 2 0.0004
131 ANAL ABSCESS 2 0.0004
132 CLUMSINESS 1 0.0004
133 INTRACRANIAL PRESSURE INCREASED 2 0.0004
134 THERAPEUTIC RESPONSE DELAYED 1 0.0004
135 PYELONEPHRITIS 3 0.0003
136 SPINAL OSTEOARTHRITIS 3 0.0003
137 INFUSION SITE REACTION 1 0.0003
138 ATYPICAL PNEUMONIA 1 0.0003
139 SYMPTOM RECURRENCE 2 0.0003
140 FOETAL GROWTH RESTRICTION 2 0.0003
141 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
142 FIBROSIS 1 0.0003
143 ILEUS 4 0.0003
144 INFUSION SITE SWELLING 2 0.0003
145 BILE DUCT STONE 1 0.0003
146 PORTAL VEIN THROMBOSIS 1 0.0003
147 THROMBOSIS IN DEVICE 1 0.0003
148 NEPHROTIC SYNDROME 2 0.0003
149 INJECTION SITE PAIN 89 0.0003
150 LARGE INTESTINE PERFORATION 2 0.0003
151 CAROTID ARTERY STENOSIS 1 0.0003
152 SPONDYLITIS 1 0.0003
153 CUTANEOUS VASCULITIS 1 0.0003
154 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
155 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
156 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
157 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
158 APHTHOUS ULCER 2 0.0003
159 FAECES HARD 1 0.0003
160 HAEMORRHOIDS 5 0.0003
161 PROCEDURAL HAEMORRHAGE 1 0.0003
162 BLOOD IRON DECREASED 3 0.0003
163 EXPOSURE VIA BREAST MILK 1 0.0003
164 OBSTRUCTION 1 0.0003
165 FUNGAL SKIN INFECTION 1 0.0002
166 CEREBRAL INFARCTION 6 0.0002
167 DEMYELINATION 1 0.0002
168 ANAPHYLACTOID REACTION 1 0.0002
169 AORTIC DISSECTION 1 0.0002
170 CYTOMEGALOVIRUS INFECTION 4 0.0002
171 INTESTINAL STENOSIS 1 0.0002
172 POOR PERIPHERAL CIRCULATION 1 0.0002
173 LUNG NEOPLASM 1 0.0002
174 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
175 PAPILLOEDEMA 1 0.0002
176 IMMUNE THROMBOCYTOPENIA 1 0.0002
177 APPENDICITIS 2 0.0002
178 ACCIDENTAL UNDERDOSE 3 0.0002
179 FIBROMYALGIA 5 0.0002
180 HORMONE LEVEL ABNORMAL 1 0.0002
181 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
182 RENAL CELL CARCINOMA 1 0.0002
183 MUCOUS STOOLS 1 0.0002
184 COLON CANCER 3 0.0002
185 ANEURYSM 1 0.0002
186 PROTEIN URINE PRESENT 1 0.0002
187 ABORTION SPONTANEOUS 8 0.0002
188 ERYSIPELAS 1 0.0002
189 TONSILLITIS 1 0.0002
190 ANAL FISTULA 1 0.0002
191 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
192 INTERSTITIAL LUNG DISEASE 9 0.0002
193 PRODUCT RESIDUE PRESENT 1 0.0002
194 HYDROCEPHALUS 1 0.0002
195 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
196 MELAENA 4 0.0002
197 DEAFNESS UNILATERAL 1 0.0002
198 CHOKING SENSATION 1 0.0002
199 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
200 INTERMENSTRUAL BLEEDING 1 0.0002
201 INTESTINAL PERFORATION 2 0.0002
202 FISTULA 2 0.0002
203 PREMATURE LABOUR 1 0.0002
204 CHOLECYSTITIS ACUTE 1 0.0002
205 PERONEAL NERVE PALSY 1 0.0002
206 HERPES VIRUS INFECTION 1 0.0002
207 ENTEROCOLITIS 1 0.0002
208 POST PROCEDURAL HAEMORRHAGE 2 0.0002
209 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
210 INJECTION SITE VESICLES 1 0.0002
211 C-REACTIVE PROTEIN INCREASED 6 0.0002
212 RECTAL HAEMORRHAGE 7 0.0002
213 INJECTION SITE MASS 6 0.0002
214 CHOLANGITIS 1 0.0002
215 INFUSION SITE EXTRAVASATION 1 0.0002
216 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
217 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
218 INJECTION SITE INDURATION 2 0.0002
219 HYPERPROLACTINAEMIA 1 0.0002
220 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
221 ORAL HERPES 3 0.0002
222 SKIN MASS 1 0.0001
223 MENINGITIS 1 0.0001
224 THERAPEUTIC RESPONSE DECREASED 9 0.0001
225 ABNORMAL LOSS OF WEIGHT 1 0.0001
226 ONYCHOCLASIS 1 0.0001
227 PAPULE 1 0.0001
228 METASTASIS 1 0.0001
229 FAECES SOFT 1 0.0001
230 UNDERDOSE 10 0.0001
231 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
232 GENERAL SYMPTOM 1 0.0001
233 COLITIS 5 0.0001
234 BOWEL MOVEMENT IRREGULARITY 1 0.0001
235 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
236 INJECTION SITE RASH 4 0.0001
237 FOOD ALLERGY 1 0.0001
238 GASTROINTESTINAL INFLAMMATION 1 0.0001
239 INCORRECT DOSE ADMINISTERED 29 0.0001
240 FURUNCLE 1 0.0001
241 BLOOD ALBUMIN DECREASED 1 0.0001
242 RENAL CYST 1 0.0001
243 ASPHYXIA 1 0.0001
244 ABNORMAL FAECES 1 0.0001
245 FLUSHING 12 0.0001
246 ERECTILE DYSFUNCTION 3 0.0001
247 MUSCULOSKELETAL DISCOMFORT 2 0.0001
248 PANCREATITIS 6 0.0001
249 IMMUNOSUPPRESSION 1 0.0001
250 INJECTION SITE BRUISING 9 0.0001
251 INJECTION SITE HAEMORRHAGE 9 0.0001
252 LUPUS-LIKE SYNDROME 1 0.0001
253 HIDRADENITIS 1 0.0001
254 PNEUMONIA BACTERIAL 1 0.0001
255 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
256 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
257 FLANK PAIN 1 0.0001
258 SQUAMOUS CELL CARCINOMA 1 0.0001
259 LEUKAEMIA 1 0.0001
260 FRACTURE 2 0.0001
261 INJECTION SITE SWELLING 8 0.0001
262 AUTOIMMUNE DISORDER 1 0.0001
263 COELIAC DISEASE 1 0.0001
264 HEPATOMEGALY 1 0.0001
265 FEEDING DISORDER 2 0.0001
266 FEELING HOT 6 0.0001
267 INJECTION SITE ERYTHEMA 12 0.0001
268 DRUG-INDUCED LIVER INJURY 3 0.0001
269 ABDOMINAL PAIN 22 0.0001
270 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
271 LIVER FUNCTION TEST INCREASED 2 0.0001
272 PHARYNGITIS STREPTOCOCCAL 1 0.0001
273 PULMONARY THROMBOSIS 1 0.0001
274 GASTROINTESTINAL PAIN 1 0.0001
275 VENTRICULAR FIBRILLATION 1 0.0001
276 HEPATOTOXICITY 2 0.0001
277 INJECTION SITE PRURITUS 6 0.0001
278 RASH PAPULAR 2 0.0001
279 THERAPY NON-RESPONDER 4 0.0001
280 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
281 HEPATIC ENZYME INCREASED 6 0.0001
282 MYOCARDITIS 1 0.0001
283 INJECTION SITE REACTION 6 0.0001
284 CARDIAC FAILURE 7 0.0001
285 VASCULITIS 1 0.0001
286 COVID-19 PNEUMONIA 1 0.0001
287 PULMONARY EMBOLISM 8 0.0001
288 CHOLECYSTITIS 1 0.0001
289 WRIST FRACTURE 1 0.0001
290 DISCOMFORT 5 0.0001
291 INJECTION SITE URTICARIA 2 0.0001
292 NASOPHARYNGITIS 15 0.0001
293 PNEUMONIA ASPIRATION 2 0.0001
294 DERMATITIS ALLERGIC 1 0.0001
295 INJECTION SITE IRRITATION 1 0.0001
296 HYPOPHAGIA 2 0.0001
297 CHEST DISCOMFORT 8 0.0001
298 INFUSION SITE PAIN 1 0.0001
299 ANAPHYLACTIC SHOCK 2 0.0001
300 DEEP VEIN THROMBOSIS 5 0.0001
301 TOOTH INFECTION 1 0.0001
302 PULMONARY CONGESTION 1 0.0001
303 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
304 HAIR TEXTURE ABNORMAL 1 0.0001
305 JOINT RANGE OF MOTION DECREASED 1 0.0001
306 QUALITY OF LIFE DECREASED 1 0.0001
307 BLOOD BILIRUBIN INCREASED 2 0.0001
308 THROAT TIGHTNESS 2 0.0001
309 RASH PRURITIC 4 0.0001
310 UVEITIS 1 0.0001
311 ANAPHYLACTIC REACTION 4 0.0001
312 ARTHRALGIA 30 0.0001
313 MASS 1 0.0001
314 INTENTIONAL DOSE OMISSION 2 0.0001
315 SUBDURAL HAEMATOMA 1 0.0001
316 HYPERSOMNIA 2 0.0001
317 MYELODYSPLASTIC SYNDROME 1 0.0001
318 INJECTION SITE HAEMATOMA 1 0.0001
319 ACUTE MYOCARDIAL INFARCTION 2 0.0001
320 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
321 LYMPHOMA 1 0.0001
322 EXPOSURE DURING PREGNANCY 4 0.0001
323 EJECTION FRACTION DECREASED 1 0.0001
324 ARRHYTHMIA 3 0.0001
325 HEAD INJURY 2 0.0001
326 ABSCESS 1 0.0001
327 SENSORY DISTURBANCE 1 0.0001
328 NIGHT SWEATS 2 0.0001
329 RASH 27 0.0001
330 MUSCLE TIGHTNESS 1 0.0001
331 DRUG INEFFECTIVE 81 0.0001
332 OSTEONECROSIS 2 0.0001
333 INFUSION RELATED REACTION 4 0.0001
334 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
335 PERICARDITIS 1 0.0001
336 FACE OEDEMA 1 0.0001
337 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
338 MYALGIA 10 0.0001
339 THERAPY CESSATION 3 0.0001
340 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
341 INFLAMMATION 3 0.0001
342 DIARRHOEA 37 0.0001
343 DRUG ERUPTION 1 0.0001
344 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
345 THIRST 1 0.0001
346 GASTROINTESTINAL DISORDER 5 0.0001
347 GOUT 1 0.0001
348 GASTROENTERITIS VIRAL 1 0.0001
349 INFECTION 8 0.0001
350 PYREXIA 19 0.0001
351 BRONCHITIS 4 0.0001
352 HEPATIC STEATOSIS 1 0.0001
353 BACTERIAL INFECTION 1 0.0001
354 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
355 SLEEP APNOEA SYNDROME 1 0.0001
356 ERUCTATION 1 0.0001
357 PRESCRIBED OVERDOSE 1 0.0001
358 HAEMATOCRIT DECREASED 1 0.0001
359 SYNCOPE 5 0.0000
360 SPINAL FRACTURE 1 0.0000
361 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
362 BODY TEMPERATURE INCREASED 1 0.0000
363 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
364 HAEMOGLOBIN DECREASED 5 0.0000
365 LUNG NEOPLASM MALIGNANT 2 0.0000
366 RIB FRACTURE 1 0.0000
367 INJECTION SITE WARMTH 1 0.0000
368 ILLNESS 5 0.0000
369 ROAD TRAFFIC ACCIDENT 2 0.0000
370 URTICARIA 8 0.0000
371 DERMATITIS 1 0.0000
372 MOUTH ULCERATION 1 0.0000
373 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
374 MENTAL DISORDER 2 0.0000
375 PRODUCT DISPENSING ERROR 1 0.0000
376 CONSTIPATION 10 0.0000
377 BLOOD PRESSURE DECREASED 3 0.0000
378 LIVER DISORDER 2 0.0000
379 DEHYDRATION 6 0.0000
380 RASH MACULO-PAPULAR 1 0.0000
381 NEOPLASM MALIGNANT 3 0.0000
382 INFLUENZA 5 0.0000
383 THROAT IRRITATION 2 0.0000
384 PARAESTHESIA 7 0.0000
385 PANCREATITIS ACUTE 1 0.0000
386 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
387 NEPHROLITHIASIS 2 0.0000
388 MUSCLE TWITCHING 1 0.0000
389 HEADACHE 27 0.0000
390 PRODUCTIVE COUGH 2 0.0000
391 PRURITUS 16 0.0000
392 LOCALISED INFECTION 1 0.0000
393 PRESYNCOPE 1 0.0000
394 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
395 COVID-19 7 0.0000
396 ABDOMINAL PAIN LOWER 1 0.0000
397 GASTRIC CANCER 1 0.0000
398 CARDIOVASCULAR DISORDER 1 0.0000
399 HAEMATOMA 1 0.0000
400 RESPIRATORY TRACT INFECTION 1 0.0000
401 HAEMORRHAGE 4 0.0000
402 DEAFNESS 1 0.0000
403 MUCOSAL INFLAMMATION 1 0.0000
404 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
405 GASTRITIS 1 0.0000
406 DEPRESSED MOOD 2 0.0000
407 CHEST PAIN 7 0.0000
408 HYPERSENSITIVITY 7 0.0000
409 THROMBOSIS 3 0.0000
410 PALLOR 1 0.0000
411 PNEUMONITIS 1 0.0000
412 INFLUENZA LIKE ILLNESS 3 0.0000
413 RESPIRATORY ARREST 1 0.0000
414 DIVERTICULITIS 1 0.0000
415 FEELING COLD 1 0.0000
416 ALOPECIA 7 0.0000
417 BLISTER 2 0.0000
418 EYE PAIN 2 0.0000
419 ASTHMA 4 0.0000
420 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
421 RED BLOOD CELL COUNT DECREASED 1 0.0000
422 LETHARGY 2 0.0000
423 BONE PAIN 2 0.0000
424 DIZZINESS 17 0.0000
425 ERYTHEMA 7 0.0000
426 PSYCHOTIC DISORDER 1 0.0000
427 OESOPHAGEAL CARCINOMA 1 0.0000
428 RESPIRATORY DISORDER 1 0.0000
429 BLOOD POTASSIUM DECREASED 1 0.0000
430 HEPATIC FAILURE 1 0.0000
431 CORONARY ARTERY DISEASE 1 0.0000
432 CONDITION AGGRAVATED 10 0.0000
433 EPILEPSY 1 0.0000
434 OROPHARYNGEAL PAIN 3 0.0000
435 SWOLLEN TONGUE 1 0.0000
436 LOSS OF CONSCIOUSNESS 4 0.0000
437 MOVEMENT DISORDER 1 0.0000
438 RHINORRHOEA 2 0.0000
439 IMPAIRED HEALING 1 0.0000
440 HEART RATE INCREASED 3 0.0000
441 DECREASED APPETITE 7 0.0000
442 VISUAL ACUITY REDUCED 1 0.0000
443 LIP SWELLING 1 0.0000
444 EYE PRURITUS 1 0.0000
445 WEIGHT DECREASED 8 0.0000
446 RASH MACULAR 1 0.0000
447 HEART RATE DECREASED 1 0.0000
448 LYMPHADENOPATHY 1 0.0000
449 SKIN BURNING SENSATION 2 0.0000
450 PNEUMONIA 9 0.0000
451 MYELOSUPPRESSION 1 0.0000
452 PANIC ATTACK 1 0.0000
453 OFF LABEL USE 24 0.0000
454 SEPSIS 3 0.0000
455 HYPOAESTHESIA 4 0.0000
456 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
457 SEIZURE 3 0.0000
458 PLASMA CELL MYELOMA 1 0.0000
459 PALPITATIONS 3 0.0000
460 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
461 EXTRA DOSE ADMINISTERED 1 0.0000
462 VISUAL IMPAIRMENT 3 0.0000
463 FALL 8 0.0000
464 POLLAKIURIA 1 0.0000
465 HYPOACUSIS 1 0.0000
466 PSORIASIS 3 0.0000
467 DYSPNOEA 13 0.0000
468 PRODUCT STORAGE ERROR 2 0.0000
469 ANGIOEDEMA 1 0.0000
470 SKIN IRRITATION 1 0.0000
471 SKIN DISCOLOURATION 1 0.0000
472 NAUSEA 17 0.0000
473 RENAL DISORDER 1 0.0000
474 BREAST CANCER 2 0.0000
475 COUGH 6 0.0000
476 CARDIAC DISORDER 2 0.0000
477 MIGRAINE 2 0.0000
478 RASH ERYTHEMATOUS 1 0.0000
479 DRUG INTOLERANCE 2 0.0000
480 FATIGUE 16 0.0000
481 DRY EYE 1 0.0000
482 BLOOD PRESSURE INCREASED 3 0.0000
483 ACUTE KIDNEY INJURY 3 0.0000
484 SINUSITIS 2 0.0000
485 ABDOMINAL PAIN UPPER 4 0.0000
486 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
487 VOMITING 9 0.0000
488 ECZEMA 1 0.0000
489 SPEECH DISORDER 1 0.0000
490 PLATELET COUNT DECREASED 2 0.0000
491 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
492 PAIN 11 0.0000
493 NECK PAIN 1 0.0000
494 FLATULENCE 1 0.0000
495 RHEUMATOID ARTHRITIS 2 0.0000
496 HERPES ZOSTER 1 0.0000
497 BACK PAIN 4 0.0000
498 SURGERY 1 0.0000
499 NASAL CONGESTION 1 0.0000
500 WHEEZING 1 0.0000
501 CATARACT 1 0.0000
502 MALAISE 7 0.0000
503 ASTHENIA 6 0.0000
504 ANAEMIA 3 0.0000
505 HYPERHIDROSIS 2 0.0000
506 BLOOD CREATININE INCREASED 1 0.0000
507 DRY SKIN 2 0.0000
508 SOMNOLENCE 3 0.0000
509 THERAPY INTERRUPTED 1 0.0000
510 DYSGEUSIA 1 0.0000
511 ACNE 1 0.0000
512 ARTHRITIS 1 0.0000
513 FEELING ABNORMAL 3 0.0000
514 PROSTATE CANCER 1 0.0000
515 CARDIAC ARREST 1 0.0000
516 RENAL IMPAIRMENT 1 0.0000
517 SKIN EXFOLIATION 1 0.0000
518 CEREBROVASCULAR ACCIDENT 2 0.0000
519 BALANCE DISORDER 1 0.0000
520 MYOCARDIAL INFARCTION 2 0.0000
521 MUSCULOSKELETAL STIFFNESS 1 0.0000
522 SUICIDAL IDEATION 1 0.0000
523 MUSCLE SPASMS 2 0.0000
524 SWELLING 1 0.0000
525 ANXIETY 3 0.0000
526 DYSPHAGIA 1 0.0000
527 NEUROPATHY PERIPHERAL 1 0.0000
528 ATRIAL FIBRILLATION 1 0.0000
529 PRODUCT DOSE OMISSION ISSUE 3 0.0000
530 PAIN IN EXTREMITY 3 0.0000
531 DYSPEPSIA 1 0.0000
532 HYPOTENSION 2 0.0000
533 ABDOMINAL DISTENSION 1 0.0000
534 THROMBOCYTOPENIA 1 0.0000
535 WEIGHT INCREASED 2 0.0000
536 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
537 DISEASE PROGRESSION 1 0.0000
538 JOINT SWELLING 1 0.0000
539 INSOMNIA 2 0.0000
540 NEUTROPENIA 1 0.0000
541 VISION BLURRED 1 0.0000
542 MEMORY IMPAIRMENT 1 0.0000
543 DEATH 6 0.0000
544 HOSPITALISATION 1 0.0000
545 PERIPHERAL SWELLING 1 0.0000
546 URINARY TRACT INFECTION 1 0.0000
547 BLOOD GLUCOSE INCREASED 1 0.0000
548 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
549 HYPERTENSION 1 0.0000
550 OVERDOSE 1 0.0000
551 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000